Article
Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
AIDS research and human retroviruses - 1 Dec 2007
Kakehasi Fabiana M, Tupinambás Unaí, Cleto Silvia, Aleixo Agdemir, Lin Elisa, Melo Victor H, Aguiar Regina A L P, Pinto Jorge A
Abstract excerpt
We assessed the development of drug resistance in women exposed to antiretroviral therapy (ART) for prevention of mother-to-child transmission (PMTCT) after 24 weeks postpartum in a prospective cohort of HIV-1-infected women. HIV-1-infected women, who received prophylactic ART during pregnancy, had genotypic resistance testing performed at the start (T1) of and 24 weeks after ART interruption (T2). The women had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.